StockNews.com Initiates Coverage on Can-Fite BioPharma (NYSE:CANF)
StockNews.com began coverage on shares of Can-Fite BioPharma (NYSE:CANF – Free Report) in a research report released on Sunday morning. The brokerage issued a hold rating on the stock. A number of other brokerages have also issued reports on CANF. HC Wainwright decreased their price target on Can-Fite BioPharma from $34.00 to $18.00 and set […]
More Stories
Creditcoin Price Down 5.4% Over Last 7 Days (CTC)
Creditcoin (CTC) traded down 1.7% against the US dollar during the 1 day period ending at 14:00 PM Eastern on...
Bitgert Price Down 14.3% This Week (BRISE)
Bitgert (BRISE) traded down 3.7% against the US dollar during the 24-hour period ending at 14:00 PM E.T. on October...
EOS Trading 4.4% Lower Over Last 7 Days (EOS)
EOS (EOS) traded down 3.7% against the US dollar during the 24-hour period ending at 14:00 PM E.T. on October...
Covenant Trading Down 41.1% Over Last Week (COVN)
Covenant (COVN) traded 3.6% lower against the US dollar during the 24 hour period ending at 14:00 PM Eastern on...
Vanguard FTSE Developed Markets ETF (NYSEARCA:VEA) Stock Holdings Trimmed by Elevated Capital Advisors LLC
Elevated Capital Advisors LLC reduced its position in Vanguard FTSE Developed Markets ETF (NYSEARCA:VEA – Free Report) by 0.1% in...
Hartford Investment Management Co. Has $6.83 Million Stock Position in American Tower Co. (NYSE:AMT)
Hartford Investment Management Co. trimmed its position in shares of American Tower Co. (NYSE:AMT – Free Report) by 1.7% during...